Zyversa Therapeutics Inc (ZVSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 25,493 | 9,137 | 107,754 | 13,833 | 7,704 |
| Operating Income | -25,493 | -9,137 | -107,754 | -13,833 | -7,704 |
| Interest Expense | 513 | 270 | -1 | 428 | 821 |
| Other Income | 202 | 0 | 0 | -607 | 442 |
| Pre-tax Income | -25,804 | -9,407 | -107,754 | -14,868 | -8,084 |
| Income Tax | -852 | 7 | -9,456 | -745 | N/A |
| Net Income Continuous | -24,952 | -9,413 | -98,298 | -14,123 | -8,084 |
| Net Income | $-24,952 | $-9,413 | $-98,298 | $-14,123 | $-8,084 |
| EPS Basic Total Ops | -4.18 | -8.48 | -1,089.70 | -935.60 | -115.38 |
| EPS Basic Continuous Ops | -4.18 | -8.48 | -1,008.18 | -547.39 | -116.96 |
| EPS Diluted Total Ops | -4.18 | -8.48 | -1,089.70 | -935.60 | -115.38 |
| EPS Diluted Continuous Ops | -4.18 | -8.48 | -1,008.18 | -547.39 | -116.96 |
| EPS Diluted Before Non-Recurring Items | N/A | -8.48 | -967.70 | N/A | N/A |
| EBITDA(a) | $-25,493 | $-9,130 | $-95,849 | $-13,783 | $-7,376 |